304 related articles for article (PubMed ID: 25077087)
1. Congenital hyperinsulinism: current status and future perspectives.
Yorifuji T
Ann Pediatr Endocrinol Metab; 2014 Jun; 19(2):57-68. PubMed ID: 25077087
[TBL] [Abstract][Full Text] [Related]
2. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism.
Snider KE; Becker S; Boyajian L; Shyng SL; MacMullen C; Hughes N; Ganapathy K; Bhatti T; Stanley CA; Ganguly A
J Clin Endocrinol Metab; 2013 Feb; 98(2):E355-63. PubMed ID: 23275527
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
[TBL] [Abstract][Full Text] [Related]
4. Congenital hyperinsulinism.
Arnoux JB; de Lonlay P; Ribeiro MJ; Hussain K; Blankenstein O; Mohnike K; Valayannopoulos V; Robert JJ; Rahier J; Sempoux C; Bellanné C; Verkarre V; Aigrain Y; Jaubert F; Brunelle F; Nihoul-Fékété C
Early Hum Dev; 2010 May; 86(5):287-94. PubMed ID: 20550977
[TBL] [Abstract][Full Text] [Related]
5. The molecular mechanisms, diagnosis and management of congenital hyperinsulinism.
Senniappan S; Arya VB; Hussain K
Indian J Endocrinol Metab; 2013 Jan; 17(1):19-30. PubMed ID: 23776849
[TBL] [Abstract][Full Text] [Related]
6. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic characterization of congenital hyperinsulinism in Spain.
Martínez R; Fernández-Ramos C; Vela A; Velayos T; Aguayo A; Urrutia I; Rica I; Castaño L;
Eur J Endocrinol; 2016 Jun; 174(6):717-26. PubMed ID: 27188453
[TBL] [Abstract][Full Text] [Related]
8. Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management.
Giri D; Hawton K; Senniappan S
J Pediatr Endocrinol Metab; 2022 Mar; 35(3):279-296. PubMed ID: 34547194
[TBL] [Abstract][Full Text] [Related]
9. Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism.
Chandran S; Peng FY; Rajadurai VS; Lu YT; Chang KT; Flanagan SE; Ellard S; Hussain K
Endocrinol Diabetes Metab Case Rep; 2013; 2013():130041. PubMed ID: 24616771
[TBL] [Abstract][Full Text] [Related]
10. Congenital Hyperinsulinism in China: A Review of Chinese Literature Over the Past 15 Years.
Wang WY; Sun Y; Zhao WT; Wu T; Wang L; Yuan TM; Yu HM
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):194-201. PubMed ID: 28270372
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
[TBL] [Abstract][Full Text] [Related]
12. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.
Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE
Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism.
Yorifuji T; Kawakita R; Hosokawa Y; Fujimaru R; Matsubara K; Aizu K; Suzuki S; Nagasaka H; Nishibori H; Masue M
Clin Endocrinol (Oxf); 2013 Jun; 78(6):891-7. PubMed ID: 23067144
[TBL] [Abstract][Full Text] [Related]
14. Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia.
Senniappan S; Sadeghizadeh A; Flanagan SE; Ellard S; Hashemipour M; Hosseinzadeh M; Salehi M; Hussain K
BMC Res Notes; 2015 Aug; 8():350. PubMed ID: 26268944
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of hyperinsulinaemic hypoglycaemia.
Galcheva S; Al-Khawaga S; Hussain K
Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):551-573. PubMed ID: 30086874
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of congenital hyperinsulinism.
Rahman SA; Nessa A; Hussain K
J Mol Endocrinol; 2015 Apr; 54(2):R119-29. PubMed ID: 25733449
[TBL] [Abstract][Full Text] [Related]
17. The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia.
Dastamani A; Güemes M; Pitfield C; Morgan K; Rajab M; Rottenburger C; Bomanji J; De Coppi P; Dattani M; Shah P
Horm Res Paediatr; 2019; 91(1):56-61. PubMed ID: 30114684
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the KCNJ11 gene (p.Val36Glu), predisposes to congenital hyperinsulinemia.
Shah IA; Rashid R; Bhat A; Rashid H; Bashir R; Asrar MM; Wani IA; Charoo BA; Radha V; Mohan V; Ganie MA
Gene; 2023 Aug; 878():147576. PubMed ID: 37336273
[TBL] [Abstract][Full Text] [Related]
19. The genetic basis of congenital hyperinsulinism.
James C; Kapoor RR; Ismail D; Hussain K
J Med Genet; 2009 May; 46(5):289-99. PubMed ID: 19254908
[TBL] [Abstract][Full Text] [Related]
20. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
